Investment backs novel feed-based sea lice treatment
Kort samengevat
German biotechnology firm AquaNab has secured investment from Finnish venture capital firm Nordic Foodtech VC to advance its novel nanoantibody platform,…
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij The Fish Site.
Lees het volledige bericht ↗